File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Ex vivo expansion of hematopoietic stem cells

TitleEx vivo expansion of hematopoietic stem cells
Authors
KeywordsEx vivo
Expansion
HSC
polymers
Small molecules
Transplantation
Issue Date1-Jun-2023
PublisherElsevier
Citation
Experimental Cell Research, 2023, v. 427, n. 1 How to Cite?
Abstract

Hematopoietic stem cells (HSCs) are multipotent progenitor cells that can differentiate into various mature blood cells and immune cells, thus reconstituting hematopoiesis. By taking advantage of the tremendous potential of HSCs, varied hereditary and hematologic diseases are promised to be alleviated or cured. To solve the contradiction between the growing demand for HSCs in disease treatment and the low population of HSCs in both cord blood and bone marrow, ex vivo HSC expansion along with multiple protocols has been investigated for harvesting adequate HSCs over the past two decades. This review surveys the state-of-the-art techniques for ex vivo HSC self-renewal and provides a concise summary of the effects of diverse intrinsic and extrinsic factors on the expansion of HSCs. The remaining challenges and emerging opportunities in the field of HSC expansion are also presented.


Persistent Identifierhttp://hdl.handle.net/10722/331438
ISSN
2021 Impact Factor: 4.145
2020 SCImago Journal Rankings: 1.197

 

DC FieldValueLanguage
dc.contributor.authorWang, Yuan-
dc.contributor.authorSugimura, Ryohichi-
dc.date.accessioned2023-09-21T06:55:44Z-
dc.date.available2023-09-21T06:55:44Z-
dc.date.issued2023-06-01-
dc.identifier.citationExperimental Cell Research, 2023, v. 427, n. 1-
dc.identifier.issn0014-4827-
dc.identifier.urihttp://hdl.handle.net/10722/331438-
dc.description.abstract<p> Hematopoietic stem cells (HSCs) are multipotent progenitor cells that can differentiate into various mature blood cells and immune cells, thus reconstituting hematopoiesis. By taking advantage of the tremendous potential of HSCs, varied hereditary and hematologic diseases are promised to be alleviated or cured. To solve the contradiction between the growing demand for HSCs in disease treatment and the low population of HSCs in both cord blood and bone marrow, ex vivo HSC expansion along with multiple protocols has been investigated for harvesting adequate HSCs over the past two decades. This review surveys the state-of-the-art techniques for ex vivo HSC self-renewal and provides a concise summary of the effects of diverse intrinsic and extrinsic factors on the expansion of HSCs. The remaining challenges and emerging opportunities in the field of HSC expansion are also presented. <br></p>-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofExperimental Cell Research-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectEx vivo-
dc.subjectExpansion-
dc.subjectHSC-
dc.subjectpolymers-
dc.subjectSmall molecules-
dc.subjectTransplantation-
dc.titleEx vivo expansion of hematopoietic stem cells-
dc.typeArticle-
dc.identifier.doi10.1016/j.yexcr.2023.113599-
dc.identifier.scopuseid_2-s2.0-85152436810-
dc.identifier.volume427-
dc.identifier.issue1-
dc.identifier.issnl0014-4827-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats